Showing results (391-400 of 661) with videos related to

Sort By:
Pageof 67
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2012
Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatinDavid Sebag-Montefiore, Helen M Meadows, David Cunningham, et al.
Surgical Endoscopy|June 14, 2024
Introduction of day-case robotic liver surgery: a case series from a tertiary hepatobiliary and pancreatic centreKai Tai Derek Yeung, Rajendran Vellaisamy, Aasim Hussain, et al.
Trials|May 29, 2020
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trialCaroline Forde, Ronan McMullan, Mike Clarke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 18, 2020
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapyH Jervoise N Andreyev, Amyn Lalji, Kabir Mohammed, et al.
Clinical Colorectal Cancer|January 27, 2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008Timothy J Price, Niall C Tebbutt, Christos S Karapetis, et al.
Neuroimage|April 21, 2006
A visual joke fMRI investigation into Theory of Mind and enhanced risk of schizophreniaDominic Marjoram, Dominic E Job, Heather C Whalley, et al.
Health Technology Assessment (Winchester, England)|March 21, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky Coyle, Caroline Forde, Richard Adams, et al.
ESMO Open|November 16, 2016
Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trialSalvatore Siena, Josep Tabernero, Gyorgy Bodoky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid TumorsEric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, et al.
British Journal of Cancer|December 20, 2023
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trialBianca Grosser, Jake Emmerson, Nic G Reitsam, et al.
Pageof 67